No Data
No Data
No Data
Crescent Biopharma Appoints David Lubner to Board of Directors
GlobeNewswireApr 28 07:30 ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
BenzingaApr 23 08:06 ET
Express News | GlycoMimetics Merger-Bound Crescent Appoints Joshua Brumm As CEO
BenzingaApr 3 07:34 ET
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics
GlobeNewswireApr 3 07:30 ET
GLYCOMIMETICS Earnings Preview: Recent $GLYC Insider Trading, Hedge Fund Activity, and More
Quiver QuantitativeMar 23 17:06 ET
Cantor Fitzgerald Initiates GlycoMimetics(GLYC.US) With Buy Rating
Moomoo NewsMar 22 02:31 ET · Ratings
This_Guy
:
I am not following it so can't give much of an opinion. It is a Bio stock so you would need to know their pipeline, trials etc, if you were to go long. I can say for a day trade or swing it is not on my radar.
It is currently trading around what the value should be. P/B ratio value = .30. Not sure if they have any catalysts coming up but maybe look into that, maybe trial announcements, upcoming conference dates etc.
Also note, they have been given delisting notice for the stock price being under 1.00 and have until mid June to regain compliance. Which means a reverse split is looming.
104765380 OP This_Guy : Ok. Thanks man..really appreciate it. we'll try to look their pipeline etc. you shld hv discord tho
This_Guy 104765380 OP : You're welcome. Maybe a discord is in my future. Maybe a website dedicated to helping new traders. It's in the back of my mind but that's about it right now.
- No more -